October 8, 2025 by drsarojpatnaik@gmail.com
Thalidomide was synthesised in 1954 and developed as a sleeping pill by the German company Chemie Grünenthal. It was marketed across Europe, Australia, and parts of Asia as a “miracle sedative.” It was considered a miracle because it was believed to be a drug that could not cause death due to overdose, leading to its promotion as one of the safest sedatives available. By 1961, it was sold in over 40 countries as a sleeping aid.
Thalidomide was particularly popular among pregnant women and was prescribed to alleviate morning sickness, anxiety, and insomnia.
What followed was a human catastrophe. In 1961, Dr. William McBride, an Australian obstetrician-gynaecologist, discovered and reported in a letter to The Lancet that thalidomide might be teratogenic, meaning it could cause severe birth defects.
October 8, 2025 by drsarojpatnaik@gmail.com
Once considered the most notorious drug in medical history, thalidomide evoked fear and outrage in the 1960s. It caused significant devastation for thousands of families, as it was linked to severe birth defects and a global scandal. After being banned and forgotten, thalidomide seemed like a closed chapter — a grim lesson in pharmaceutical ethics.
However, decades later, an unexpected twist occurred: thalidomide made a comeback, not as a villain but as a saviour. Today, it is a frontline treatment for multiple myeloma, a type of blood cancer, providing hope where despair once prevailed.
This is the remarkable story of how one of medicine’s darkest hours gave rise to one of its most unlikely heroes.